Amorós Morales, L.C.; Gómez Bergna, S.M.; Marchesini, A.; Scalise, M.L.; Gonzalez, N.; Ferrelli, M.L.; Candolfi, M.; Romanowski, V.; Pidre, M.L.
RIPK1 in Diffuse Glioma Pathology: From Prognosis Marker to Potential Therapeutic Target. Int. J. Mol. Sci. 2025, 26, 5555.
https://doi.org/10.3390/ijms26125555
AMA Style
Amorós Morales LC, Gómez Bergna SM, Marchesini A, Scalise ML, Gonzalez N, Ferrelli ML, Candolfi M, Romanowski V, Pidre ML.
RIPK1 in Diffuse Glioma Pathology: From Prognosis Marker to Potential Therapeutic Target. International Journal of Molecular Sciences. 2025; 26(12):5555.
https://doi.org/10.3390/ijms26125555
Chicago/Turabian Style
Amorós Morales, Leslie C., Santiago M. Gómez Bergna, Abril Marchesini, MarÃa Luján Scalise, Nazareno Gonzalez, M. Leticia Ferrelli, Marianela Candolfi, VÃctor Romanowski, and Matias L. Pidre.
2025. "RIPK1 in Diffuse Glioma Pathology: From Prognosis Marker to Potential Therapeutic Target" International Journal of Molecular Sciences 26, no. 12: 5555.
https://doi.org/10.3390/ijms26125555
APA Style
Amorós Morales, L. C., Gómez Bergna, S. M., Marchesini, A., Scalise, M. L., Gonzalez, N., Ferrelli, M. L., Candolfi, M., Romanowski, V., & Pidre, M. L.
(2025). RIPK1 in Diffuse Glioma Pathology: From Prognosis Marker to Potential Therapeutic Target. International Journal of Molecular Sciences, 26(12), 5555.
https://doi.org/10.3390/ijms26125555
